Thyrotropin (TSH) is composed of two subunits: an alpha subunit, common to pituitary TSH and pituitary and placental gonadotropins, and a unique bet subunit (TSHbeta). Thyroid hormone and its nuclear receptor (c-erbA) bind to and regulate the transcription of a variety of genes including both TSH subunit genes (TSHalpha, TSHbeta) and the rat growth hormone gene (rGH). However, the molecular mechanisms that determine whether a thyroid hormone DNA response element (TRE) negatively (e.g., TSHbeta) or positively (e.g., rGH) regulates gene expression are completely unknown. The proposed studies will determine whether the location, orientation, or a specific DNA sequence defines a TRE as inhibitory or stimulatory. DNA transfection studies in a variety of cell lines will be performed using chimeric constructs containing inhibitory and stimulatory TREs in a variety of locations and orientations. Moreover, since preliminary evidence suggests that an additional nuclear protein(s), other than the thyroid hormone receptor, is involved in the molecular mechanism of thyroid hormone inhibition of human TSHbeta expression (hTSHbeta) an additional goal of these studies will be to define further the cis-acting elements to which this protein(s) binds, and whether it is cell-specific. DNA transfection studies using deletions and mutations of the human TSHbeta TRE in parallel with DNase I footprinting studies of this TRE with nuclear extracts from TSH-secreting and non-secreting cell lines and tissues will be utilized to accomplish this goal. These studies will provide new insight into thyroid hormone action and allow a more detailed model of thyroid hormone action at any TRE to be developed. Since additional nuclear proteins in the thyrotroph may be involved in the molecular mechanism of thyroid hormone inhibition of hTSHbeta expression, the second major goal of these studies will be to define cis-acting elements responsible for thyroid hormone regulation and thyrotroph-specific expression of the hTSHbeta gene. To accomplish this goal, in vitro DNA transfection studies (utilizing chimeric hTSHbeta constructs) and DNA binding assays (DNase I footprinting) will be correlated with in vivo expression of chimeric hTSHbeta genes in transgenic mice. The long range goal of these studies is to determine the interrelationship between cell- specific expression and thyroid hormone regulation of the hTSHbeta gene in the anterior pituitary. Ultimately, a greater understanding of thyroid hormone action in man may be gained.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DK043653-05
Application #
2143128
Study Section
Endocrinology Study Section (END)
Project Start
1991-06-01
Project End
1996-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Safer, J D; O'Connor, M G; Colan, S D et al. (1999) The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone. J Clin Endocrinol Metab 84:3099-109
Safer, J D; Cohen, R N; Hollenberg, A N et al. (1998) Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone. J Biol Chem 273:30175-82
Langlois, M F; Zanger, K; Monden, T et al. (1997) A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation. J Biol Chem 272:24927-33
Safer, J D; Langlois, M F; Cohen, R et al. (1997) Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Mol Endocrinol 11:16-26
Hollenberg, A N; Monden, T; Madura, J P et al. (1996) Function of nuclear co-repressor protein on thyroid hormone response elements is regulated by the receptor A/B domain. J Biol Chem 271:28516-20
Medeiros-Neto, G; Herodotou, D T; Rajan, S et al. (1996) A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest 97:1250-6
Cohen, O; Flynn, T R; Wondisford, F E (1995) Ligand-dependent antagonism by retinoid X receptors of inhibitory thyroid hormone response elements. J Biol Chem 270:13899-905
Hollenberg, A N; Monden, T; Flynn, T R et al. (1995) The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements. Mol Endocrinol 9:540-50
Hollenberg, A N; Monden, T; Wondisford, F E (1995) Ligand-independent and -dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini. J Biol Chem 270:14274-80
Flynn, T R; Hollenberg, A N; Cohen, O et al. (1994) A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J Biol Chem 269:32713-6

Showing the most recent 10 out of 13 publications